Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Ann Pharm Fr ; 77(4): 302-312, 2019 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-31027754

RESUMEN

Timolol is a non-cardioselective beta blocker and has different combined ophthalmic dosage forms for treatment of glaucoma. This research introduce an HPLC method for the separation of three drugs used in combination with timolol simultaneously by applying isocratic mobile phase system in a single run and the same detection wavelength with short time. The drugs included in the separation procedures are; dorzolamide, brinzolamide, and brimonidine. The HPLC method was carried out through a single mobile phase system, which contains acetonitrile: 0.05M phosphate buffer at the ratio of 30:70, respectively at pH 3.5 and wavelength of 220nm. The method, regarding its simplicity allows determination of the studied drugs simultaneously using single run in about 8minutes. The method was rectilinear in the ranges of concentration: 1.25-25µg/mL for timolol, 4-80µg/mL for dorzolamide, 5-50µg/mL for brinzolamide and 2-20µg/mL for brimonidine. Different factors affecting the separation are thoroughly studied. The developed method was validated based on the official guidelines and the results were compared statistically with previously published methods and showed non-significant difference.


Asunto(s)
Antagonistas Adrenérgicos beta/análisis , Glaucoma/tratamiento farmacológico , Timolol/análisis , Tartrato de Brimonidina/análisis , Cromatografía Líquida de Alta Presión , Combinación de Medicamentos , Composición de Medicamentos , Límite de Detección , Soluciones Oftálmicas , Estándares de Referencia , Reproducibilidad de los Resultados , Sulfonamidas/análisis , Tiazinas/análisis , Tiofenos/análisis
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA